Sin categoría

GP1025C Advanced Ovarian Cancer patients in the US using PARP inhibitor

We currently have a new study in the US about Ovarian Cancer. The study will involve a 60 min interview for which participants will be compensated with $150 USD and with additional $75 USD for providing a proof of diagnosis to be eligible to participate. There is no medical treatment being provided as part of this study; it is completely non-interventional. We were wondering if you could collaborate with us

GP0951D Esclerosis Múltiple en España

We have a new study in Spain. En IQVIA, una organización de investigación clínica, estamos trabajando en un proyecto cuyo objetivo es comprender los programas de apoyo al paciente (PSP) que existen en el ámbito de la esclerosis múltiple (EM). En concreto, como alguien que vive con EM nos gustaría conocer su opinión sobre cuáles son los mayores retos en el campo de la esclerosis múltiple. Además, nos gustaría conocer

GP0331 Atopic Dermatitis in the US, UK and Canada

We currently have a study for participants in the US/UK/Canada to learn more about the experiences of patients with Atopic Dermatitis. The study consists of a 60-minute-long web-assisted interview. We appreciate the time that patients invest in these interviews, for this reason we are offering an incentive of 125USD/90GBP/150CAD as a token of appreciation for taking part. If you need more information or are interested, please do not hesitate to

GP1086D – POTS Patients in the US

Global Patients is conducting an interview study with adult patients (>18 years old) diagnosed with Postural Orthostatic Tachycardia Syndrome (POTS) after having a COVID-19 infection. Symptoms of POTS often include light-headedness, fainting, and rapid heartbeat when standing up. These symptoms are often relieved by sitting or lying down again. The aim of the study is to understand how people experience this disease and how it may affect their lives. The

GP1113D Elderly patients for device research about BP in US and FR

We are currently looking for individuals who are 75 years of age or older to take part in a paid qualitative research interview. Study participation involves an in-person interview of approximately 60 minutes in length with a trained interviewer. The interview will occur at a date and time convenient for you, and you will have the option for it to be conducted at your home or at a nearby facility.

GP1189B Eosinophilic Gastritis and Duodenitis

We are working with Evidera, a health research company, to conduct an interview study and askparticipants to give feedback on a symptom questionnaire. The results of this study may help inform thedevelopment of future treatments. Your participation in this study is voluntary. Study participants must be between 12 years of age or olderunderstand and speak English and live in the United States. Additional eligibility requirements will beconfirmed through initial screening

GP0190E NMOSD Patients and Caregivers

We would like to hear from adults of all ages and backgrounds who are living with NMOSDor providing care or support for someone who is and who are interested in participating ina 1-hour online interview to discuss their experiences. The interviews will be guided by anexperienced moderator and are scheduled to take place during February/March 2023.If you are interested in taking part, we will first arrange a 10-minute call with

GP0119E PNH study

At Global Patients, an Iqvia business, we are helping to conduct a study to better understand what it is like to have paroxysmal nocturnal hemoglobinuria (PNH). We are looking for adults (age 18 or older) who live in the US and are currently being treated for PNH. Study participants will complete an online survey, answering questions about their experience of PNH. The online survey takes about 45 minutes to complete.

GP0184E Atopic dermatitis study

We are recruiting patients with atopic dermatitis in the United States to participate in an interview as part of a research study. During the interview, you will be asked about what it is like to have atopic dermatitis, including the symptoms you experience and how they have impacted your life. You will also be asked to read and provide feedback on questionnaires meant to help measure the symptom experience and

GP1096D PTSD patients in the US

IQVIATM, a healthcare research firm (www.iqvia.com), is currently conducting an interview study to better understand how individuals living with Post-Traumatic Stress Disorder (PTSD) may experience difficulties with dealing with their emotions. This study is sponsored by a pharmaceutical company that is working on developing therapies for individuals with PTSD. We are seeking individuals diagnosed with PTSD who are between 18 and 65 years old. This interview study will involve participation

GP0143E StudyOpportunity for adolescents and adults with Idiopathic Inflammatory Myopathies

A new research study is recruiting adults with polymyositis (18 years and older) and adolescents (12-17 years old) and young adults with dermatomyositis. The purpose of this study is to gather feedback on a general health questionnaire to evaluate its relevance and clarity to patients with IIM. What is involved? Participation in this study includes a single, approximately 60-minute interview with the option of using either telephone or online videoconferencing

GP0656D Cold Urticaria patients and caregivers in the US

At Global Patients, an IQVIA Businessn, and IQVIATM (www.iqvia.com), a healthcare research firm, is currently conducting a research project with patients who have a history of chronic inducible cold urticaria and/or their caregivers. The research will involve participating in a telephone interview lasting up to 90 minutes. In appreciation of your time, we are offering an honorarium of $185 for each interview. The interview will focus on the understanding of

GP0153E MF and SS Patients on Poteligio treatment in the UK

We are launching a new study, where we want to learn more about people living with cutaneous T-cell lymphoma (CTCL)  and their caregivers. We are interested in understanding the clinical and emotional impacts of treatment and the impacts on day-to-day life. We would also like to understand where you feel information regarding treatment is missing or could be improved. The research will take the form of a 60-minute one-to-one interview.

GP0153E MF and SS Patients on Poteligio treatment in the US

We are launching a new study, where we want to learn more about people living with cutaneous T-cell lymphoma (CTCL)  and their caregivers. We are interested in understanding the clinical and emotional impacts of treatment and the impacts on day-to-day life. We would also like to understand where you feel information regarding treatment is missing or could be improved. The research will take the form of a 60-minute one-to-one interview.

GP1070A Alzheimer caregivers WATDI in US

We are conducting a research study which will involve interviews with caregivers of people diagnosed with mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease (AD).This study consists of an online interview, which will last around 90 minutes. Participants will receive an honorarium of $235 as a bank transfer, cheque or e-transfer.There is no medical treatment being provided as part of this study. The information shared will be reported in a

GP0978C – Relapsed Follicular Lymphoma

At Global Patients, we are conducting a new study and would really value your opinion. The purpose of the research is to account the experiences and preferences of people diagnosed with cancer in the US and in the UK. The study will take the form of a 45-minute web-assisted interview.  As a token of appreciation for their time, participants will receive a 100USD/100GBP honorarium paid upon completion of the interview.